A preliminary report from the Centers for Disease Control and Prevention shows that more than 72,000 deaths from opioid overdose were reported for 2017. . . . → Read More: Infographic – 72,000 Opioid Overdose Deaths in 2017
|
|||||
A bioengineering lab devised a way to quickly detect and treat bacteria responsible for tooth decay with a combination of X-rays and a non-toxic compound in nanoscale particles. . . . → Read More: Nanoparticle Process Designed to Detect, Treat Oral Bacteria 
A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine 
Pain drugs made from peptides, small protein-like compounds, and guided by antibodies are being developed as alternatives to prescription opioids to treat moderate to severe pain. . . . → Read More: Peptide Pain Drugs in Development Aimed at Alternative Targets 
A clinical trial shows a single medication with low doses of three common drugs reduces high blood pressure in more people with the condition than the normal care. . . . → Read More: Low-Dose Triple Pill Reduces Blood Pressure in More People 
A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million 
A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration. . . . → Read More: FDA Approves RNA-Interference Nerve Disease Therapy 
A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions. . . . → Read More: Cancer Drug Delivery Through Milk Particles Under Study 
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments 
Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
